Impilo to Enhance Supply Chain Visibility for Current Health

PHILADELPHIA, Oct. 6, 2025 /PRNewswire/ — Impilo, a leading provider in enabling at-home healthcare through logistics and operations support, announces new support for Current Health, the leading partner for shifting the delivery of acute and complex care to home and community settings.

The collaboration will strengthen Current Health’s ability to deliver world-class service to healthcare organizations and patients by offering enhanced speed, visibility, and reliability across its nationwide supply chain.

For more than 10 years, Current Health has partnered with healthcare organizations to launch and scale care-at-home programs that expand inpatient capacity, improve patient outcomes, and support the shift of complex inpatient care to home and community settings.

Current Health is also the country’s largest provider of remote technology and services for outpatient and community delivery of complex cell and gene therapies, CAR-T, bispecific immunotherapies, and other emerging treatments, helping to serve patients closer to home while ensuring access to breakthrough cures.

Through this new relationship, Current Health will leverage Impilo’s advanced logistics platform and real-time supply chain visibility to track, manage, and optimize the movement of devices, equipment and supplies to patient homes and back, helping to ensure that patients receive critical supplies on time and with confidence.

“Healthcare at home depends on the reliable and timely delivery of medical device kits,” said Josh Stein, Founder and CEO of Impilo. “Our platform and offering were built to bring transparency and efficiency to the supply chain, and we are thrilled to partner with Current Health to support their mission of enabling safe, effective, and scalable complex care at home.”

“Breakthrough therapies and the most advanced care can only deliver on their promise if our healthcare system can deliver them reliably and at scale,” said Chris McGhee, CEO and co-founder of Current Health. “With Impilo, we’re enhancing our ability to give our customers the end-to-end infrastructure to deliver complex care and advanced treatments where patients need them most.”

About Impilo
Impilo’s plug-and-play operational infrastructure allows healthcare organizations to build and scale connected care programs with confidence. Impilo simplifies logistics by providing end-to-end supply chain visibility, device tracking, warehousing, fulfillment, and streamlined procurement workflows for providers and payors alike. As a healthcare-focused logistics and support partner, Impilo supports a wide range of organizations, including payors, value-based care entities, medical device companies, community health centers, and digital health organizations, delivering reliable, scalable, and patient-centered supply chain solutions. Learn more at impilo.health.

About Current Health
Current Health partners with health systems and life sciences companies to enable the shift of acute and complex care from inpatient facilities to outpatient, home and community settings. For more than a decade, the company has helped organizations expand capacity, improve outcomes, and deliver complex cell and gene therapies, CAR-T, bispecific immunotherapies, and other emerging treatments, helping to serve patients closer to home while improving access to breakthrough care. Learn more at currenthealth.com.

Contact:


press@impilo.health

View original content to download multimedia:https://www.prnewswire.com/news-releases/impilo-to-enhance-supply-chain-visibility-for-current-health-302575356.html

SOURCE Impilo

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

9 hours ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

9 hours ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

9 hours ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

9 hours ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

9 hours ago